Posts tagged:

Argenta Regulatory Insights - Spring 2026

Argenta acquires Shawnee sterile fill-finish manufacturing site dedicated to animal health

Navigating the path from 'molecule to market': Argenta's Project Management Office (PMO)

Better palatability, better performance: How soft chews are changing the game in animal medicine

Leadership changes as Argenta restructures RD&I division to improve customer offering

Partnering for progress: Recap of the Animal Health, Nutrition and Technology Innovation Europe conference

Market trends for ectoparasiticides: Navigating a growing need

Argenta invests in expanded blister packaging capabilities in Dundee, Scotland, UK

Three ways a CDMO helps propel your microspheres-based treatment to market

Four key challenges to overcome during early microspheres development

Microspheres: What are animal drug developers so excited about?

Argenta combines legacy brands to further advance animal health: 'One Brand, One Vision'